Expression of E-cadherin and β-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival

被引:93
作者
Zhou, YN [1 ]
Xu, CP
Han, B
Li, M
Qiao, L
Fang, DC
Yang, JM
机构
[1] Third Mil Med Univ, SW Hosp, Dept Gastroenterol, Chongqing 400038, Peoples R China
[2] First Teaching Hosp, Lanzhou Med Coll, Lanzhou 730000, Gansu Province, Peoples R China
[3] Lanzhou Med Coll, Dept Pathol, Lanzhou 730000, Gansu Province, Peoples R China
[4] Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Richmond, VA 23298 USA
关键词
D O I
10.3748/wjg.v8.i6.987
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: The E-cadherin-catenin complex is important for cell-cell adhesion of epithelial cells. Impairment of one or more components of this complex is associated with poor differentiation and increased invasiveness of carcinomas. We evaluated the expression pattern of E-cadherin and beta-catenin in gastric carcinoma and dysplasia and analyzed their relationship with tumor clinicopathological features and patient survival. METHODS: Immunohistochemical staining of E-cadherin and beta-catenin was performed from paraffin specimens of 163 gastric carcinomas, 44 gastric mucosal dysplasia, and 25 intestinal metaplasia, 28 atrophic gastritis and 12 healthy controls. RESULTS: Normal membrane staining was observed in intestinal metaplasia, atrophic gastritis and control biopsy specimens for E-cadherin and beta-catenin. 36% and 16% of gastric dysplasia were stained abnormally for E-cadherin and beta-catenin respectively. Abnormal expression of E-cadherin and beta-catenin was demonstrated in 46% and 44% of gastric carcinoma respectively. Abnormal expression of E-cadherin and beta-catenin occurred more significantly in Borrmann III/IV than in Borrmann I/II type (P<0.005, respectively). A significantly higher proportion of signet-ring, mucinous and tubular adenocarcinomas were abnormally expressed for E-cadherin and beta- catenin as compared with papillary adenocarcinomas (chi(2)=8.47,P<0.005, and chi(2)=7.05, P<0.01, respectively). Morever, abnormal E-cadherin and beta-catenin staining occurred more frequently in diffuse than in intestinal type of tumor (chi(2)=18.18 and 17.79, P<0.005, respectively). There was a significant correlation between abnormal beta-catenin expression and positive lymph node metastasis. A survival advantage was noted in tumors retaining normal membranous expression of beta-catenin, independent of type, grade, or stage of the disease (P<0.0005). CONCLUSION: Abnormal expression of the E-cadherin-catenin complex occurs frequently in gatric carcinoma, closely related to its histogenesis. Abnormal expression of the E-cadherin- catenin complex in gastric dysplasia may be an early event in the tumorigenesis. The close correlation with poor survival suggests that abnormal beta-catenin may be a useful prognostic marker.
引用
收藏
页码:987 / 993
页数:7
相关论文
共 67 条
[1]   The use of molecular biology in diagnosis and prognosis of gastric cancer [J].
Becker, KF ;
Keller, G ;
Hoefler, H .
SURGICAL ONCOLOGY-OXFORD, 2000, 9 (01) :5-11
[2]   Functional interaction of beta-catenin with the transcription factor LEF-1 [J].
Behrens, J ;
vonKries, JP ;
Kuhl, M ;
Bruhn, L ;
Wedlich, D ;
Grosschedl, R ;
Birchmeier, W .
NATURE, 1996, 382 (6592) :638-642
[3]   CADHERIN EXPRESSION IN CARCINOMAS - ROLE IN THE FORMATION OF CELL-JUNCTIONS AND THE PREVENTION OF INVASIVENESS [J].
BIRCHMEIER, W ;
BEHRENS, J .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1994, 1198 (01) :11-26
[4]  
Blok P, 1999, HISTOPATHOLOGY, V34, P410
[5]   Soluble E-cadherin is a valid prognostic marker in gastric carcinoma [J].
Chan, AOO ;
Lam, SK ;
Chu, KM ;
Lam, CM ;
Kwok, E ;
Leung, SY ;
Yuen, ST ;
Law, SYK ;
Hui, WM ;
Lai, KC ;
Wong, CY ;
Hu, HC ;
Lai, CL ;
Wong, J .
GUT, 2001, 48 (06) :808-811
[6]   Cooccurrence of reduced expression of α-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer [J].
Che, XM ;
Hokita, S ;
Natsugoe, S ;
Tanabe, G ;
Baba, M ;
Takao, S ;
Kuroshima, K ;
Aikou, T .
ONCOLOGY, 1999, 57 (02) :131-137
[7]  
Chun YS, 2001, CANCER, V92, P181, DOI 10.1002/1097-0142(20010701)92:1<181::AID-CNCR1307>3.0.CO
[8]  
2-J
[9]  
CORREA P, 1992, CANCER RES, V52, P6735
[10]   CELL-ADHESION AND EPITHELIAL DIFFERENTIATION [J].
FLEMING, S .
JOURNAL OF PATHOLOGY, 1991, 164 (02) :95-100